HCA Healthcare Inc. logo

HCA Healthcare Inc. (HCA)

Market Open
24 Feb, 15:23
NYSE NYSE
$
524. 75
-11.22
-2.09%
$
119.03B Market Cap
13.35 P/E Ratio
0.55% Div Yield
239,370 Volume
18.19 Eps
$ 535.97
Previous Close
Day Range
522.64 536.15
Year Range
295 552.9
Want to track HCA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HCA earnings report is expected in 58 days (23 Apr 2026)
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock

Here's Why HCA Healthcare (HCA) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 9 months ago
HCA Healthcare (HCA) Boasts Earnings & Price Momentum: Should You Buy?

HCA Healthcare (HCA) Boasts Earnings & Price Momentum: Should You Buy?

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Zacks | 9 months ago
Here's Why HCA Healthcare (HCA) is a Strong Value Stock

Here's Why HCA Healthcare (HCA) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 9 months ago
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term

Why HCA Healthcare (HCA) is a Top Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Zacks | 9 months ago
3 Reasons Why Growth Investors Shouldn't Overlook HCA (HCA)

3 Reasons Why Growth Investors Shouldn't Overlook HCA (HCA)

HCA (HCA) could produce exceptional returns because of its solid growth attributes.

Zacks | 9 months ago
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term

Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 10 months ago
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term

Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 10 months ago
HCA Healthcare Q1 Earnings Beat on Growing Patient Volumes

HCA Healthcare Q1 Earnings Beat on Growing Patient Volumes

HCA continues to witness growth in reported and same-facility admissions. The company reaffirms 2025 guidance.

Zacks | 10 months ago
Compared to Estimates, HCA (HCA) Q1 Earnings: A Look at Key Metrics

Compared to Estimates, HCA (HCA) Q1 Earnings: A Look at Key Metrics

The headline numbers for HCA (HCA) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 10 months ago
HCA Healthcare (HCA) Beats Q1 Earnings and Revenue Estimates

HCA Healthcare (HCA) Beats Q1 Earnings and Revenue Estimates

HCA Healthcare (HCA) came out with quarterly earnings of $6.45 per share, beating the Zacks Consensus Estimate of $5.77 per share. This compares to earnings of $5.36 per share a year ago.

Zacks | 10 months ago
HCA Healthcare Tops Revenue Expectations

HCA Healthcare Tops Revenue Expectations

HCA Healthcare (HCA 1.64%), a prominent player in the healthcare sector, announced robust first-quarter results for 2025 on Friday, April 25, that surpassed market expectations. The company recorded an adjusted EPS of $6.45 for Q1 2025, exceeding the anticipated $5.75.

Fool | 10 months ago
HCA Healthcare posts higher profit on strong demand for medical care

HCA Healthcare posts higher profit on strong demand for medical care

Hospital operator HCA Healthcare said on Friday its first-quarter profit rose nearly 9%, as more people underwent elective procedures and sought medical care due to a rise in flu cases.

Reuters | 10 months ago
Loading...
Load More